Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Levomepromazine
levomepromazine
Routinely available
Local application
13/12/2023
Indication
Treatment of chemotherapy-induced vomiting in paediatrics.
Therapeutic Area
Central nervous system
Status Description
Routinely available in line with local or regional guidance
Formulation
5mg/ml oral solution sugar free
Comments
December 2023 - Routinely available in line with local or regional guidance. Included on the ERF for Specialist Initiation. Classified for use under policy for the use of unlicensed medicine.